The weekly litigation news digest is live. Subscribe now

IP Verse

Solid State Forms Of Selexipag - EP3344607

The patent EP3344607 was granted to Teva Pharmaceuticals on Nov 6, 2019. The application was filed on Sep 2, 2016 under application number EP16766424A. The patent is currently recorded with a legal status of "Revoked".

EP3344607

TEVA PHARMACEUTICALS
Application Number
EP16766424A
Filing Date
Sep 2, 2016
Status
Revoked
Jul 19, 2024
Publication Date
Nov 6, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HGFAug 5, 2020HGFADMISSIBLE
CHIESI FARMACEUTICIFeb 6, 2020BIANCHETTI & MINOJA WITH TREVISAN & CUONZO IPSADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2014148469
DESCRIPTIONUS2014155414
DESCRIPTIONUS7205302
DESCRIPTIONUS8791122
INTERNATIONAL-SEARCH-REPORTUS2014155414
OPPOSITIONEP1400518
OPPOSITIONUS2014155414
OPPOSITIONWO2017040872

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents